Vivani Medical Inc. Common Stock (DE) (VANI)
VANI trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.18
-0.84% on the day
Market cap
$106.4M
Micro cap
Revenue · 2025
$0
No prior year to compare
Net income · 2025
$26.6M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1266806/000175392626000548/0001753926-26-000548-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | VANI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001266806 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | $26.6M |
| Operating income | -$27.6M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $16.2M |
| Total assets | $39.4M |
| P/E (computed) | 4.0× |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-25 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-16 |
| Latest proxy DEFA 14A | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 835 recent filings. All filings on EDGAR.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| STXS | Stereotaxis Inc. | $1.06 | -7.02% | $106.2M |
| HYPR | Hyperfine Inc. | $0.8515 | -6.06% | $90.3M |
| NRXS | Neuraxis Inc. | $6.50 | -3.27% | $81.6M |
| OM | Outset Medical Inc. | $4.06 | +1.25% | $76.3M |
| ECOR | electroCore Inc. | $8.39 | -9.59% | $75.6M |
| HSDT | Solana Company Class A Common Stock (DE) | $2.35 | -1.67% | $152.3M |
| FOCL | EDAP TMS S.A. | $4.20 | -2.33% | $193.0M |
| POCI | Precision Optics Corporation Inc. | $4.56 | -0.98% | $50.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier